ALNY ALNYLAM PHARMACEUTICALS INCUS
Everything important about one stock — one page ·
$255.96
+2.55%
Quote 25 Sept 2026, 23:00 KSA
Day move+2.55%
$255.96
Easy Score42
Weak
Indicators6/18
6 bullish · 11 neutral · 1 bearish
Trend — 6 months−19.3%
Down
BullishNeutralBearish
Trend — daily 6 months
Down -19.3% — falling but reclaiming its average
Trend — weekly 3 years
Up +47.2% — buyers are in control
Company financials — direction 2021–2025
| Metric | Then → now | Change | Meaning |
|---|---|---|---|
| Revenue | $ 0.7B → $ 3.7B | +460% | the business is growing |
| Net margin | -129% → 8.4% | +137.0 pts | turned profitable |
| EPS | $-7.20 → $2.33 | — | turned profitable |
42
Easy Score — Weak
Analysts 38
Buy 29Hold 9Sell 0
Key indicators — and what each means now 6 bullish / 1 bearish of 18
Bullish 6Neutral 11Bearish 1
| RSI (14) 56 | healthy — not overbought, not oversold | |
| vs 200-day MA -17% | below its long-term average = long-term pressure | |
| MACD bullish | momentum currently favors buyers | |
| Volume 0.7× | normal activity — no unusual crowd behavior | |
| September 3y win rate 67% | September closed green 2 of the last 3 years |
The read
Strong profitability at a rich price (P/E 42). Daily trend down, weekly trend up. Whole picture, not advice.
Analysis through completed session of 25 Sept, 3:00 am KSA · Full analysis →